Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Isogenica Limited

Isogenica was launched in December 2000 by Dr Kevin FitzGerald and Dr Simon Kerry through a £1.8m private equity placement. Isogenica's vision is to become a world leader in the commercial exploitation of molecular evolution technologies.

The Company has a highly innovative, proprietary, in vitro molecular evolution technology called Covalent Display Technology (CDT), which can be used for a wide range of applications including:



the accelerated discovery of peptide, protein and antibody therapeutics;

the development of high affinity ligands for the validation of targets arising from genomics/proteomics studies;

the development of high affinity ligands for diagnostics and medical imaging applications;

the development of high affinity ligands for the production of bioseparations media.

Isogenica intends to generate income from its molecular evolution technologies in three ways:



· through an in-house therapeutic discovery programme;



· though strategic collaborations with partner companies (e.g. for target validation purposes);



· by offering technology licenses to partner companies in discrete application areas


Contact Details:
Babraham Hall, Babraham
Cambridge
CB2 4AT
United Kingdom
Tel:01223 496722
Fax:01223 496 721
Email:simon.kerry@isogenica.com
WWW:

www.isogenica.com/




Loading...

Recent Publications by Isogenica Limited:

An in vitro selection strategy for conferring protease resistance to ligand binding peptides.
One drawback to the use of peptides as therapeutics has been their...
17th September, 2009
Isogenica Ltd., The Mansion, Chesterford Research Park, Little Protein Eng Des Sel. 2009 Nov;22(11):691-8. Epub 2009 Sep 15.
DOI Direct Link
CIS display: In vitro selection of peptides from libraries of protein-DNA complexes.
We describe the development of an in vitro library selection system (CIS...
18th June, 2004
Isogenica Ltd., Babraham Hall, Babraham CB2 4AT, United Kingdom. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2806-10. Epub 2004 Feb 23.
DOI Direct Link

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 456 times since April 2007, the link to the organisation's website has been followed 82 times

Recent Search Terms used to find this page: isogenica | isogenica peptide deals | isogenica ltd babraham | isogenica | isogenica | Isogenica | isogenica | Isogenica | isogenica | Isogenica Ltd | .

Search for more companies in Cambridge

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Isogenica Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.